| |
INTENDED AUDIENCE
Retina specialists and ophthalmologists
LEARNING OBJECTIVES
Upon completion of this CME activity, the participant should be able to:
- Describe the evolution of fluidics in vitreous surgery and identify the first generally accepted techniques in vitreous surgery.
- Define port-based flow limiting and discuss the value of high resistance at the port during vitreous surgery.
- Explain how high cutting rates affect fluidics during vitreous surgery.
ACCREDITATION AND DESIGNATION STATEMENTS
 Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Rush University Medical Center designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release Date: April 2008. The opinions or views expressed in this educational program are those of the participants and do not necessarily reflect the opinions or recommendations of Alcon Laboratories or Rush University Medical Center. The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this educational program.
Expiration Date: April 30, 2009.
Estimated Time for Completion: 1.5 hours
RUSH DISCLOSURE POLICY
It is the policy of the Rush University Medical Center Office of Continuing Medical Education to ensure that its CME activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CME. Everyone who is in a position to control the content of an education activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months. If there are relationships that create a conflict of interest, these must be resolved by the CME Course Director in consultation with the Office of Continuing Medical Education prior to the participation of the faculty member in the development or presentation of course content.
 
|
 |
CME COURSE DIRECTOR
Kirk H. Packo, MD
Director, Department of Ophthalmology Rush University/Medical Center
Chicago, Illinois
FACULTY
Steve Charles, MD
Clinical Professor of Ophthalmology, University of Tennessee, Memphis and Hamilton Eye Institute, Memphis, Tennessee
Adjunct Professor of Ophthalmology, Columbia College of Physicians & Surgeons,
New York, New York
DISCLOSURES
Kirk H. Packo, MD
Grant/Research/Support:
Alcon Laboratories, Inc.
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Steve Charles, MD
Grant/Research/Support: None
Consultant: Alcon Laboratories, Inc.
Speakers’ Bureau: None
Stock Shareholder: None
|
|
